Bellevue Funds (Lux) -Bellevue Obesity Solutions B USD - Accumulating
LU0415392322
Bellevue Funds (Lux) -Bellevue Obesity Solutions B USD - Accumulating/ LU0415392322 /
NAV 08.05.2024
Diff.-0,9900
Ertragstyp
Ausrichtung
Fondsgesellschaft
512,1500 USD
-0,19%
thesaurierend
Aktien
Waystone M.Co.(Lux) ▶
Zeitraum: 6 Monate 1 Jahr 2 Jahre 3 Jahre 5 Jahre
Anzahl an Fonds: 10 20 50
Titel
ISIN
Performance
Volatilität
Sharpe Ratio
1.
BIT Biotech Opportunities S
DE000A3DCA95
+32,61%
32,27%
0,89
2.
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) SGD
LU0320765992
+19,47%
17,71%
0,88
3.
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse Z (acc) GBP
LU0774687577
+18,82%
17,96%
0,84
4.
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse I (acc) USD
LU0195948822
+18,31%
18,80%
0,77
5.
Abaris Biotech.Opportunities A CHF
LU2210124454
+33,26%
38,30%
0,77
6.
F.Biotechnology Dis.Fd.W USD
LU0976566496
+18,24%
18,85%
0,77
7.
F.Biotechnology Dis.Fd.Z USD
LU1446800499
+17,85%
18,83%
0,75
8.
Abaris Biotech.Opportunities A EUR
LU2210105669
+31,35%
37,58%
0,73
9.
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) USD
LU0109394709
+17,31%
18,81%
0,72
10.
Abaris Biotech.Opportunities A USD
LU2210105313
+31,38%
39,39%
0,70
...
83.
Bellevue Funds (Lux) -Bellevue Obesity Solutions B USD - Accumulating
LU0415392322
-4,22%
12,65%
-0,64